Cytotoxic activities of Mannich bases of chalcones and related compounds

Journal of Medicinal Chemistry

Volumn 41, Issue 7, 1998, Pages 1014-1026

  Dimmock, Jonathan R ^a   Murthi Kandepu, N ^a   Hetherington, Mark ^a   Wilson Quail, J ^a   Pugazhenthi, Uma ^a   Sudom, Athena M ^a   Chamankhah, Mahmood ^a   Rose, Patricia ^b   Pass, Eric ^b   Allen, Theresa M ^c   Halleran, Sarah ^c   Szydlowski, Jen ^c   Mutus, Bulent ^d   Tannous, Marie ^d   Manavathu, Elias K ^e   Myers, Timothy G ^f   De Clercq, Erik ^g   Balzarini, Jan ^g  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF WINDSOR   (Canada)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHALCONE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MANNICH BASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MOLECULAR MODEL; MOUSE; MUTAGEN TESTING; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; RAT; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; TUMOR CELL LINE; X RAY CRYSTALLOGRAPHY;

EID: 15144357004     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970432t     Document Type: Article

References (55)

1. Yit, C. C.; Das, N. P. Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Lett. 1994, 82, 65-72.
2. Satomi, Y. Inhibitory effects of 3 -methyl-3-hydroxychalcone on proliferation of human malignant tumor cells and on skin carcinogenesis. Int. J. Cancer 1993, 55, 506-514.
3. Wattenberg, L. W.; Coccia, J. B.; Galhaith, A. R. Inhibition of carcinogen-induced pulmonary and mammary carcinogenesis by chalcone administered after carcinogen exposure. Cancer Lett. 1994, 83, 165-169.
4. Edwards, M. L.; Stemerick, D. M.; Sunkara, S. P. Chalcone derivatives useful in controlling growth of tumor tissue and their preparation. Eur. Pat, Appl. EP 288,794, Nov. 2, 1988; Chem. Abstr. 1989, 111, 17706t.
5. Edwards, M. L.; Stemerick, D. M.; Sunkara, S. P. Chalcone derivatives useful in controlling growth of tumor tissue and their preparation. Eur. Pat, Appl. EP 288,794, Nov. 2, 1988; Chem. Abstr. 1989, 111, 17706t.
6. Dimmock, J. R.; Kumar, P. Anticancer and cytotoxic properties of Mannich bases. Curr. Med. Chem. 1997, 4, 1-22.
7. Baluja, G.; Municio, A. M.; Vega, S. Reactivity of some α,β-unsaturated ketones towards sulphydryl compounds and their antifungal activity. Chem. Ind. 1964, 2053-2054.
8. Dimmock, J. R. Raghavan, S. K.; Logan, B. M.; Bigam, G. E. Antileukemic evaluation of some Mannich bases derived from 2-arylidene-1,3-diketones. Eur. J. Med. Chem. 1983, 18, 248-254.
9. Benvenuto, J. A.; Connor, T. H.; Monteith, D. K.; Laidlaw, J. L.; Adams, S. C.; Matney, T. S.; Theiss, J. C. Degradation and inactivation of antitumor drugs. J. Pharm. Sci. 1993, 82, 988-991.
10. Dimmock, J. R.; Sidhu, K. K.; Chen, M.; Reid, R. S.; Allen, T. M.; Kao, G. Y.; Truitt, G. A. Evaluation of some Mannich bases of cycloalkanones and related compounds for cytotoxic activity. Eur. J. Med. Chem. 1993, 28, 313-322.
11. Craig, P. N. Interdependence between physical parameters and selection of substituent groups for correlation studies. J. Med. Chem. 1971, 14, 680-684.
12. Topliss, J. G. A manual method for applying the Hansch approach to drug design. J. Med. Chem. 1977, 20, 463-469.
13. Boyd, M. R. In Cancer: Principles and Practice of Oncology Update; De Vita, V. T., Jr., Hellman, S., Rosenberg, S. A., Eds.; J. B. Lippincott: Philadelphia, 1989; Vol. 3, No. 10, pp 1-12.
14. Schiestl, R. H.; Gietz, R. D.; Mehta, R. D.; Hastings, P. J. Carcinogens induce intrachromosomal recombination in yeast. Carcinogenesis 1989, 10, 1445-1455.
15. Porter, R. J.; Cereghino, J. J.; Gladding, G. D.; Hessie, B. J.; Kupfererg, H. J.; Scoville, B.; White, B. G. Antiepileptic drug development program. Cleveland Clin. Q. 1984, 51, 293-305.
16. Tramontini, M.; Angiolini, L. Mannich Bases: Chemistry and Uses; CRS Press: Boca Raton, 1994; pp 33, 67.
17. Suifness, M.; Douros, J. In Methods in Cancer Research, Volume XVI, Part A; De Vita, V. T., Jr., Busch, H., Eds.; Academic Press: New York, 1979; p 84.
18. Weinstein, J. N.; Myers, T. G.; O'Connor, P. M.; Friend, S. H.; Fornace, A. J.; Kohn, K. W.; Foho, T.; Bates, S. E.; Rubenstein, L. V.; Anderson, N. L.; Buolamwini, J. K.; van Osdol, W. W.; Monks, A. P.; Scudiero, D. A.; Sausville, E. A.; Zaharevitz, D. W.; Bunow, B.; Johnson, G. S.; Wittes, R. E.; Paull, K. D. An information-in tensive approach to the molecular pharmacology of cancer. Science 1997, 275, 343-349.
19. Paull, K. D.; Hamel, E.; Malspeis, L. Prediction of biochemical mechanism of action from the in vitro antitumor screen of the National Cancer Institute. In Cancer Chemotherapeutic Agents; Foye, W. O., Ed.; American Chemical Society: Washington, DC, 1995; pp 9-45 and references therein.
20. Weinstein, J. N.; Kohn, K. W.; Grever, M. R.; Viswanadhan, V. N.; Rubinstein, L. V.; Monks, A. P.; Scudiero, A. P.; Welch, L.; Koutsoukos, A. D.; Chiausa, A. J.; Paull, K. D. Neural computing in cancer drug development: predicting mechanism of action. Science 1992, 258, 447-451.
21. Koutsoukos, A. D.; Rubinstein, L. V.; Faragi, D.; Kalyandrug, S.; Weinstein, J. N.; Paull, K. D.; Simon, R. M. Discrimination techniques applied to the NCI in vitro antitumor drug screen: predicting biochemical mechanism of action. Stat Med. 1994, 13, 719-730.
22. Dimmock, J. R.; Kumar, P.; Quail, J. W.; Pugazhenthi, U.; Yang, J.; Chen, M.; Reid, R. S.; Allen, T. M.; Kao, G. Y.; Cole, S. P. C.; Batist, G.; Baizarini, J.; De Clercq, E. Synthesis and cytotoxic evaluation of some styryl ketones and related compounds. Eur. J. Med. Chem. 1995, 30, 209-217.
23. Hall, I. H.; Lee, K.-H.; Mar, E. C.; Starnes, C. O.; Waddell, T. G. Antitumor agents 21. A proposed mechanism of inhibition of cancer growth by tenulin and helenalin and related cyclopentenones. J. Med. Chem. 1977, 20, 333-337.
24. Braude, E. A.; Sondheimer, F. Studies in light absorption. XI. Substituted benzaldehydes, acetophenones and related compounds. Effects of steric conformations on the electronic spectra of conjugated systems. J. Chem. Soc. 1955, 3754-3766.
25. Braude, E. A.; Sondheimer, F.; Forbes, W. F. Steric effects in the electronic spectra of organic compounds. Nature 1954, 173, 117-119.
26. Schulmann, J. W.; Sabio, M. L.; Disch, R. L. Recognition of cholinergic agonists by the muscarinic receptor. Acetylcholine and other agonists with the NCCOCC backbone. J. Med. Chem. 1983, 26, 817-823.
27. Hamon, N. W.; Bassendowski, D. L.; Wright, D. E.; Dimmock, J. R.; Noble, L. M. Effect of antineoplastic and cytotoxic Mannich bases derived from conjugated styryl ketones on mitochondrial respiration in rat liver cells. J. Pharm. Sci. 1978, 67, 1539-1542 and references therein.
28. Sexton, D. J.; Dimmock, J. R.; Mutus, B. A spectrophtometric glutathione S-transferase assay displaying alpha-class selectivity utilizing 1-p-chlorophenyl-4,4-dimethyl-5-diethylamino-l-penten-3-one hydrobromide. Biochem. Cell Biol. 1993, 71, 98-101.
29. Rashid, K. A.; Mullin, C. A.; Mumma, R. O. Structure-mutagenicity relationships of chalcones and their oxides in the Salmonella assay. Mutat. Res. 1986, 169, 71-79.
30. Pappano, N. B.; Centorbi, O.; Blanco, S. E.; Debattita, N. B.; Ferreti, F. H. Relation of the carbonyl region with the bacteriostatic activity of chalcones. Commun. Biol. 1986, 5, 179-191.
31. Tsuchiya, H.; Sato, M.; Akagiri, M.; Takagi, N.; Tanaka, T.; Iinuma, M. Anti-Candida activity of synthetic hydroxychalcones. Pharmazie 1994, 49, 756-758.
32. Gevorgyan G. A.; Agababyan A. G.; Mndzhoyan, O. L. Advances in the chemistry of β-aminoketones. Russ. Chem. Rev. 1984, 53, 561-581.
33. Unicler, S. A. French Patent 2, 1975, 253, 503; Chem. Abstr. 1976, 84, 89825c.
34. Unicler, S. A. French Patent 2, 1975, 253, 503; Chem. Abstr. 1976, 84, 89825c.
35. Dimmock, J. R.; Jonnalagadda, S. S.; Phillips, O. A.; Erciyas, E., Shyam, K., Semple, H. A. Anticonvulsant properties of some Mannich bases of conjugated arylidene ketones. J. Pharm. Sci. 1992, 81, 436-440.
36. Dimmock, J. R.; Kirkpatrick, D. L.; Negrave, L. E.; Russell, K. L.; Pannekoek, W. J. Preparation of some hydrazones of conjugated styryl ketones and related compounds for evaluation principally as antineoplastic agents. Can. J. Pharm. Sci. 1981, 16, 1-7.
37. Böhme, H.; Hartke, K. α-Halogenated amines. VII. The cleavage of aminals and α-dialkylamino ethers with carboxylic acid halides. Chem. Ber. 1960, 93, 1305-1309.
38. Gautier, J. A.; Miocque, M.; Quan, D. Q. Mannich reaction on p-hydroxyacetophenone. Compt. Rend. 1964, 258, 3731-3734.
39. Sipos, Gy.; Sirokman F. Chalcone formation by substituted acetophenones and p-hydroxybenzaldehyde. Nature 1964, 202, 489.
40. Baranski, A. S. MicroVoltametry software, Department of Chemistry, University of Saskatchewan, 1994.
41. Chu, K. C. The Quantitative Analysis of Structure-Activity Relationships. In The Basis of Medicinal Chemistry, 4th ed.; Wolff, M. E., Ed.; John Wiley and Sons: New York, 1980; Part I, p 401.
42. Taft, R. W., Jr. Separation of Polar, Steric and Resonance Effects in Reactivity. In Steric Effects in Organic Chemistry; Newman, M. S., Ed.; John Wiley and Sons: New York, 1956; p 591.
43. Sokal, R. R.; Michener, C. D. A statistical method for evaluating systematic relationships. University Kansas Sci. Bull. 1958, 38, 1409-1438.
44. Gabe, E. J.; LePage, Y.; Charland, J. P.; Lee, F. L.; White, P. S. An interactive program system for structure analyses. J. Appl. Crystallogr. 1989, 22, 384-387.
45. Sheldrick, G. M. SHELXL-93. Program for the Refinement of Crystal Structures, University of Göttingen, Germany, 1993.
46. International Tables for X-ray crystallography; Kynoch Press: Birmingham, 1974; Vol. IV.
47. Phillips, O. A.; Nelson, L. A.; Knaus, E. E.; Allen, T. M.; Fathi-Afsar, R. Synthesis and cytotoxic activity of pyridylthio, pyridyl-sulfinyl and pyridosulfonyl methyl acrylates. Drug Design Delivery 1989, 4, 121-127.
48. Balzarini, J.; De Clercq, E.; Mertes, M. P.; Shugar, D.; Torrence, P. F. 5-substituted 2-deoxyuridines: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthetase. Biochem. Pharmacol. 1982, 31, 3673-3682.
49. Grever, M. R.; Schepartz, S. A.; Chabner, B. A. The National Cancer Institute: Cancer drug discovery and development program. Semin. Oncol. 1992, 19, 622-638.
50. Lacks, S.; Greenberg, J. R. Complementary specificity of restriction endonucleases of Diplococcus pneumoniae with respect to DNA methylation. J. Mol. Biol. 1977, 114, 153-168.
51. Kaatz, G.; Barriere, S.; Schaberg, D.; Fekety, R. The emergence of resistance to ciprofloxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother. 1987, 20, 753-758.
52. Manavathu, E. K.; Alangaden, G. J.; Lerner, S. A. A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus. Can. J. Microbiol. 1996, 42, 960-964.
53. Jones, R. N.; Barry, A. L.; Gavan, T. L.; Washington, J. A. Susceptibility tests: microdilution and macrodilution broth procedures. In Manual of Clinical Microbiology, 4th ed; Lennette, E. H., Balows, A., Hausler, W. J., Jr.; Shadomy, H. J., Eds.; American Society Microbiology: Washington, DC, 1985; pp 972-977.
54. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, 3rd ed.; Approved Standard M7-A3. National Committee for Clinical Standards: Villanova, PA, 1993.
55. Reference method for broth dilution antifungal susceptibility testing of yeasts; Publication M27-P. National Committee for Clinical Laboratory Standards: Villanova, PA, 1992.